Antibody-Drug Conjugates in Breast Cancer: Spotlight on HER2
Rachel O. Abelman(Massachusetts General Hospital), Aditya Bardia(UCLA Health), Arielle J. Medford(Harvard University), Laura M. Spring(Massachusetts General Hospital)
Cited by 12
Related Papers
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells
|Science Translational Medicine|2013|1.1k
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
|New England Journal of Medicine|2019|1k